RE:RE:RE:RE:RE:RE:RE:John Folwer - TIME FOR AN UPDATE!!!Projections/ estimates are of little value to us at this time JRS, as the industry and market is all new and there is little historical data/ info to base any dependable estimates on....the same applies to SP, as there will be no material change until revenues are realized. Until the date of legalization is confirmed there little to no change in SP levels or manipulation....if legal rec is not confirmed for mid Aug or early Sept within this week or next we will be lucky to see legal rec this year, which will be reflected in the SP.
No customer, other than existing customers, will be ordering FIREweed until legalization is established and there is a market available that they can sell that product....if Trudeau confirms the mid Aug date he has specified previously, which would have to happen this week to allow 2mos of final prep time for all parties, Fowler's phone will be ringing off the hook and will continue much that way for the next 12mos or so until market supply catches up to demand.
The product branding, "sun grown by 7ACRES", will then have it's feet wet and start to determine the level of Brand loyalty FIREweed has and allow for more dependable/ accurate sales and revenue data on which to base realistic projections going forward...I think Fowler has it set up well and knows what quality product is and will be able to deliver what we have invested for, but will expect those results or move on, JMHO....Opt
Supreme's cost of production to market will allow FIREweed to be competitive in the marketplace and the quality of product will yield higher net margins on higher sales volumes.
JRSDIRECT wrote: Supreme is different than most of the other LPs given the B2B model. They can build their operation and management team but unfortunately it's difficult to build SP value because they really can't create a projection as other LPs who manufacture and distribute to the end-user.
Supreme is dependant on the supply agreements of other LPs to either suppliment a strain/quality that they do not offer or to simply provide additional capacity for common strains.
There are several notable LPs listed as customer/partners on their website but until those companies start signing supply agreements (including monetary value) it's only then that Supreme can start to provide to their Shareholders what their revenue projection is.
B2B is a double-edge sword; you save the cost for end user infrastucture but you are dependant on the LP (and their demand).
I mentioned my thoughts about B2B a couple months back (and just got hammered on the board) - but I will restate, if Canopy/Aurora become the house hold name; then retail investors may purchase their shares because it's the name they know. Regardless of the fact that Supreme is suppling Aurora, the retail investor may not be aware. So given the removal of 'brand' to the investor, Supreme is signficantly reliant on their financial reports to solely drive the SP.
Obivously that may sound like a stupid statement, all companies rely on their financial statments to drive SP, but the point is, Supreme may not have the 'hype and brand' factor.
You buy Nike Shoes? Tell me the name of the company in India that makes them (and the name is not Nike)
And to be clear, I like the B2B model; it has it's pros but you can't negate the cons.